A histamine H4 receptor antagonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

JNJ-10191584 (maleate)

Item No. 42265

Technical Information
Formal Name
1-[(5-chloro-1H-benzimidazol-2-yl)carbonyl]-4-methyl-piperazine, 2Z-butenedioate
CAS Number
869497-75-6
Synonyms
  • VUF 6002
Molecular Formula
C13H15ClN4O • C4H4O4
Formula Weight
Purity
≥98%
Formulation
A solid
DMSO: Sparingly Soluble: 1-10 mg/mLPBS (pH 7.2): Slightly Soluble: 0.1-1 mg/ml
SMILES
O=C(O)/C=C\C(O)=O.O=C(N1CCN(CC1)C)C(NC2=C3)=NC2=CC=C3Cl
InChi Code
InChI=1S/C13H15ClN4O.C4H4O4/c1-17-4-6-18(7-5-17)13(19)12-15-10-3-2-9(14)8-11(10)16-12;5-3(6)1-2-4(7)8/h2-3,8H,4-7H2,1H3,(H,15,16);1-2H,(H,5,6)(H,7,8)/b;2-1-
InChi Key
KOTJFAYEELTYCZ-BTJKTKAUSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    JNJ-10191584 is a histamine H4 receptor antagonist (Ki = 79.42 nM).1 It is selective for the histamine H4 receptor over the histamine H3 receptor (Ki = 3,981 nM). JNJ-10191584 inhibits eosinophil and mast cell chemotaxis (IC50s = 530 and 138 nM, respectively).2 It decreases colonic injury in a rat model of TNBS-induced colitis when administered at doses of 30 and 100 mg/kg and reduces colonic mucosal and submucosal thickness at 100 mg/kg in the same model.3 JNJ-10191584 (6 mg/kg) reduces the percentage of Th1, Th9, Th17, and regulatory T cells in the spleen, the expression of a variety of cytokines, including IfngIl9, and Tgfb1, in the brain, and the development of experimental autoimmune encephalomyelitis (EAE) in mice.4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Terzioglu, N., van Rijn, R.M., Bakker, R.A., et alSynthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H4 receptor antagonists. Bioorg. Med. Chem. Lett. 14(21), 5251-5256 (2004).

    2. Venable, J.D., Cai, H., Chai, W., et alPreparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: Potent human histamine H4 antagonists. J. Med. Chem. 48(26), 8289-8298 (2005).

    3. Varga, C., Horvath, K., Berko, A., et alInhibitory effects of histamine H4 receptor antagonists on experimental colitis in the rat. Eur. J. Pharmacol. 522(1-3), 130-138 (2005).

    4. Aldossari, A.A., Assiri, M.A., Ansari, M.A., et alHistamine H4 receptor antagonist ameliorates the progression of experimental autoimmune encephalomyelitis via regulation of T-cell imbalance. Int. J. Mol. Sci. 24(20), 15273 (2023).